NeoGenomics rises after winning patent infringement lawsuit against Natera

Natera

29/08/2025 12:37

** Shares of biotech co NeoGenomics NEO.O rise 10.9% to $8 premarket

** Co wins summary judgment in patent infringement lawsuit against Natera NTRA.O

** Co says the court stated that it will dismiss Natera's claims against NeoGenomics

     ** The court order means that NEO remains free to sell its early breast cancer screening test called RaDaR ST assay - co

** The diagnostic device is a sequencing test for the detection of minimal residual disease (MRD) and recurrence of breast cancer

** Up to last close, NEO down 56.3% YTD

 (Reporting by Sneha S K)

 ((Sneha.SK@thomsonreuters.com;))